Woodline Partners LP Codex Dna, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.8 - $6.45 $540,145 - $1.94 Million	-300,081 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.12 - $10.36 $592,633 - $1.49 Million	-143,843 Reduced 32.4%	300,081 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$6.31 - $11.96 $397,530 - $753,480	-63,000 Reduced 12.43%	443,924 $4.79 Million
Q3 2021 Nov 15, 2021	BUY	$10.15 - $19.88 $132,203 - $258,937	13,025 Added 2.64%	506,924 $5.64 Million
Q2 2021 Aug 16, 2021	BUY	$17.76 - $22.0 $8.77 Million - $10.9 Million	493,899 New	493,899 $10.9 Million

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.